1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Details of the disposition;

A. On December 31, 2014, while serving in Company B, the Plaintiff filed an application for medical care benefits with the Defendant on January 14, 2015, alleging that the Plaintiff was diagnosed as “cerebrovascopic refluoral refratal refratal refratal refratal refratal refratal, double alleys, brains, and brain refratal refratal refr

B. However, on April 15, 2015, the Defendant rendered a disposition of non-approval for medical care to the Plaintiff, and the Plaintiff appealed and filed an administrative litigation seeking the revocation of the said disposition (this Court Decision 2015Gudan58341).

The court dismissed the Plaintiff’s claim, and the Seoul High Court also dismissed the Plaintiff’s appeal (2016du54589), but the Supreme Court reversed it and remanded the case to the Seoul High Court (2016du5589). Accordingly, the Defendant rendered a disposition of medical care approval for each of the above injury and disease on August 21, 2017.

(B) On November 21, 2017, the Plaintiff obtained the approval for medical care even for the “amend mental disorder” (hereinafter “the instant injury”) and “amendic mental disorder” (hereinafter “amendic mental disorder”).

The Plaintiff submitted to the Defendant on October 14, 2019 a medical treatment plan (hereinafter “instant medical treatment plan”) with the content that the Plaintiff provides outpatient treatment (medical treatment and mental treatment) from October 7, 2019 to January 6, 2020 for the instant medical treatment (hereinafter “instant medical treatment plan”).

On November 5, 2019, the Defendant had a view that it is reasonable for the Plaintiff to terminate medical treatment after October 6, 2019 due to the symptoms of the advisory society on August 16, 2019 as the result of the advisory society on August 16, 2019, and the Plaintiff submitted a new medical treatment plan and received medical advice thereafter, and as a result, there is a opinion that it is reasonable to terminate medical treatment at a premium rate on October 6, 2019 and it is reasonable to terminate medical treatment as of October 6, 2019, and it is not recognized after the aggravation of medical treatment."

[The facts that there is no dispute over the basis of recognition, Gap evidence 1 to 5, Eul evidence 3, the purport of the whole pleadings.

2. The instant disposition is lawful.